Invesaro

Stocks Health care DROR

OTC · Health care

Dror Ortho-Design, Inc. (DROR)

It posted a net loss of $2.5M. In fiscal 2025 capital spending exceeded operating cash flow by $2.1M. At June 30, 2026 it held $93.6K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.

Watch DROR in 60 seconds
Price
$0.01
+25.00% on the day · September 25, 2026
52-week range $0.00 to $0.03
Market cap
$8.8M

What Dror Ortho-Design, Inc. does

Dror Ortho-Design, Inc. is registered with the SEC under industry code SIC 3843 (Dental Equipment & Supplies). Its shares trade on OTC under the ticker DROR.

Revenue and profit by year

Revenue
FY20: $1K $1K FY20FY21: $2.6K $2.6K FY21
Net income
FY19: -$115.9K -$115.9K FY19FY19: -$134.2K -$134.2K FY19FY20: -$168K -$168K FY20FY21: -$170.5K -$170.5K FY21FY22: -$1.7M -$1.7M FY22FY23: -$3.6M -$3.6M FY23FY24: -$5.8M -$5.8M FY24FY25: -$2.5M -$2.5M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$2.2M-$2.5M$0.00-$2.1M
2024n/a-$5.2M-$5.8M-$0.01-$2.8M
2023n/a-$4.4M-$3.6M-$0.01n/a
2022n/a-$1.7M-$1.7M$0.00n/a
2021$2.6K-$170.3K-$170.5K$0.00n/a
2020$1K-$167.7K-$168K$0.00n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 17, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 18, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What Dror Ortho-Design, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 25, 2026
  2. September 16, 2026
  3. September 9, 2026
  4. August 28, 2026
  5. August 19, 2026
  6. July 30, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.00 versus $0.00.
  7. May 13, 2026
    Quarterly report 10-Q · period to March 31, 2026Diluted EPS $0.00 versus $0.00.
  8. May 1, 2026
  9. April 1, 2026
  10. March 4, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 5, 2026. Insider transactions on SEC

Who owns DROR

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Orin Hirschman13G, passive with 1 related filers 9.9% 95,662,500 January 29, 2026
Congregation Ahavas Tzdokah Vchesed Inc.13G, passive 6.44% 61,667,440 June 20, 2025

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about DROR

What does Dror Ortho-Design, Inc. do?

Dror Ortho-Design, Inc. is registered with the SEC under industry code SIC 3843 (Dental Equipment & Supplies). Its shares trade on OTC under the ticker DROR.

Is Dror Ortho-Design, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $2.5M.

When did Dror Ortho-Design, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shareholder vote results from September 25, 2026.

Similar companies

Compare DROR with

Compare DROR with any company

Follow DROR

Get an email when Dror Ortho-Design, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow DROR: get an email when it files

Where the numbers come from

Financial figures are the values Dror Ortho-Design, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.